High activity iodine 125 endocurietherapy for recurrent skull base tumors.
Experience with endocurietherapy of skull base tumors is reviewed. We present our cases of recurrent pituitary hemangiopericytoma, radiation-induced recurrent meningioma, recurrent clival chordoma, recurrent nasopharyngeal cancer involving the cavernous sinus, and recurrent parotid carcinoma of the skull base which were all successfully retreated with high-activity 125iodine (I-125) permanent implantation.
Kumar
P P
PP
Division of Radiation Oncology, University of Nebraska College of Medicine, Omaha.
Good
R R
RR
Leibrock
L G
LG
Mawk
J R
JR
Yonkers
A J
AJ
Ogren
F P
FP
D000230:Adenocarcinoma / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D002817:Chordoma / Q000532:radiotherapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D006393:Hemangiopericytoma / Q000532:radiotherapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D008579:Meningioma / Q000532:radiotherapy; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy; D010307:Parotid Neoplasms / Q000532:radiotherapy; D010911:Pituitary Neoplasms / Q000532:radiotherapy; D012888:Skull Neoplasms / Q000532:radiotherapy; D014057:Tomography, X-Ray Computed
D007457:Iodine Radioisotopes